Machine learning classifies chronic kidney disease stages from clinical variables, suggesting improved accuracy over traditional methods.
Chronic kidney disease (CKD) is a major non-communicable disease burden affecting approximately 10–15% of the global adult population. Accurate and early classification of CKD progression stages is critical for timely clinical intervention and improved patient outcomes. Conventional staging relies on laboratory estimation of glomerular filtration rate (eGFR); however, machine learning methods offer an opportunity to classify multi-stage CKD from routinely collected clinical variables with high accuracy.
No takes yet. Share an insight, caveat, or question.
Dubey et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: